Target intelligence / Profile preview

Ribosomal protein L13 pseudogene 5 (RPL13P5)

Target
RPL13P5
Molecular classification
Other (processed pseudogene; not protein-coding)
01

Overview

Ribosomal protein L13 pseudogene 5 (RPL13P5) is classified as a processed pseudogene in the human genome. It is a non-coding DNA sequence that originated from the RPL13 gene, which encodes a structural protein of the 60S ribosomal subunit. RPL13P5 has no protein product, biological activity, or known involvement in human disease or drug response. Processed pseudogenes such as RPL13P5 arise through retrotransposition events, in which mRNA is reverse-transcribed and inserted back into the genome, typically without regulatory elements needed for expression. RPL13 pseudogenes are common in the human genome, part of a large pool of ribosomal protein pseudogenes resulting from evolutionary genomic rearrangement. The RPL13P5 locus does not produce functional protein, is not involved in signaling, transport, or transcription, and has no known pharmacological or diagnostic relevance. In summary, RPL13P5 is a pseudogene with no therapeutic, diagnostic, or biological function, appropriately classified as ‘other’ in molecular family and not a target for drugs or biomarkers.

Other names
RPL13-2RPL13LRPL13_4_1199RRPL13LRPL13-2 pseudogeneRPL13P5

Beyond the preview

Go deeper on Ribosomal protein L13 pseudogene 5 (RPL13P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L13 pseudogene 5 (RPL13P5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call